Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways / Resistance to Targeted Anti-Cancer Therapeutics Bd.15 (PDF)
(Sprache: Englisch)
This volume comprehensively covers the multiplicity and diversity of mechanisms underlying patient resistance to currently approved anti-cancer drugs, including tyrosine kinase inhibitors and monoclonal antibodies, blockers of growth factor receptors and...
sofort als Download lieferbar
eBook (pdf)
Fr. 177.00
inkl. MwSt.
- Kreditkarte, Paypal, Rechnung
- Kostenloser tolino webreader
Produktdetails
Produktinformationen zu „Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways / Resistance to Targeted Anti-Cancer Therapeutics Bd.15 (PDF)“
This volume comprehensively covers the multiplicity and diversity of mechanisms underlying patient resistance to currently approved anti-cancer drugs, including tyrosine kinase inhibitors and monoclonal antibodies, blockers of growth factor receptors and their downstream pathways, which play essential functions in cancer progression. Each chapter will cover a specific group of targets and the cognate drugs, along with molecular modes of innate and evolving resistance.
Autoren-Porträt
Yosef Yarden, PhD, is Professor, Department of Biological Regulation, The Weizmann Institute of Science, Israel.
Bibliographische Angaben
- 2018, 1st ed. 2018, 242 Seiten, Englisch
- Herausgegeben: Yosef Yarden, Moshe Elkabets
- Verlag: Springer-Verlag GmbH
- ISBN-10: 3319679325
- ISBN-13: 9783319679327
- Erscheinungsdatum: 28.03.2018
Abhängig von Bildschirmgrösse und eingestellter Schriftgrösse kann die Seitenzahl auf Ihrem Lesegerät variieren.
eBook Informationen
- Dateiformat: PDF
- Grösse: 4.89 MB
- Ohne Kopierschutz
- Vorlesefunktion
Sprache:
Englisch
Kommentar zu "Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways / Resistance to Targeted Anti-Cancer Therapeutics Bd.15"
0 Gebrauchte Artikel zu „Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways / Resistance to Targeted Anti-Cancer Therapeutics Bd.15“
| Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
|---|
Schreiben Sie einen Kommentar zu "Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways / Resistance to Targeted Anti-Cancer Therapeutics Bd.15".
Kommentar verfassen